Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
143.77
-2.92 (-1.99%)
At close: Sep 15, 2026, 4:00 PM EDT
144.27
+0.50 (0.35%)
Pre-market: Sep 16, 2026, 6:00 AM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $57.4 billion as of September 15, 2026. Its market cap has increased by 527.49% in one year.
Market Cap
57.40B
Enterprise Value
51.78B
1-Year Change
527.49%
Ranking
Category
Stock Price
$143.77
ChartMarket Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $57.40B, an increase of 838.12%. That is a compound annual growth rate of 33.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 57.40B | 398.13% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 130.64B |
| Regeneron Pharmaceuticals | 78.04B |
| argenx SE | 61.97B |
| Revolution Medicines | 43.68B |
| BeOne Medicines AG | 39.40B |
| Royalty Pharma | 33.70B |
| Alnylam Pharmaceuticals | 33.28B |
| Roivant Sciences | 29.49B |